First Trust Indxx Medical Devices ETF (MDEV) has seen unusual trading volume, which is 14× higher than its average daily volume.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Among its largest positions, West Pharmaceutical Services has drawn fresh analyst attention, with Morgan Stanley and Barclays both raising their price targets after strong first-quarter results, while the broader Street still sees the stock as a Strong Buy. Edwards Lifesciences, another key holding, has seen multiple analysts reiterate Buy ratings and lift or reaffirm price targets, reflecting a Moderate Buy consensus and expectations for further upside. Align Technology is in focus ahead of its upcoming first-quarter earnings report, where Wall Street is looking for solid profit and revenue, and Baxter International is digesting a reiterated Buy rating from Barclays even as it works through recent losses and mixed fundamentals highlighted in its latest earnings release.